Evidence map›Paper›PMID 42047430›Full record

ArticleJournal of midwifery & women's health

Optimizing Hereditary Cancer Risk Assessment and Genetic Testing Workflow in Interprofessional Women's Health Practice: A Multicenter Survey of Advanced Practice Providers.

Elaine Mielcarski, Dana Karanik, Heather Bagley, Edith Smith, Amanda Steele, Logan Schneider, Lauren Lenz, Royce T Adkins

Abstract readMulticenter Study
In one paragraph

Article in Journal of midwifery & women's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elaine MielcarskiAssociates for Women's Medicine, North Syracuse, New York.
Dana KaranikAssociates for Women's Medicine, North Syracuse, New York.
Heather BagleyMyriad Genetics, Salt Lake City, Utah.
Edith SmithMyriad Genetics, Salt Lake City, Utah.
Amanda SteeleMyriad Genetics, Salt Lake City, Utah.
Logan SchneiderMyriad Genetics, Salt Lake City, Utah.
Lauren LenzMyriad Genetics, Salt Lake City, Utah.
Royce T AdkinsMyriad Genetics, Salt Lake City, Utah.

Funding

Myriad Genetics
6 · The paper itself

Abstract

introductionAdvanced practice providers (APPs), including certified nurse-midwives (CNMs)/certified midwives and nurse practitioners, are well positioned to meet the growing demand for women's health care services. In interprofessional obstetric and gynecologic settings, APPs' scope of practice includes performing hereditary cancer risk assessments (HCRAs) and genetic evaluations, comparable with physicians. However, time constraints, limited confidence, and inadequate resources may hinder APPs' ability to routinely and effectively incorporate HCRA and genetic testing into practice. PROCESS: This prospective, single-arm health care quality improvement initiative introduced workflow innovations and tools to improve HCRA workflow. This intervention included training on using online family history screening and virtual patient education tools within a standardized HCRA. Metrics related to genetic evaluation and testing completion and the experiences of women and APP respondents were recorded preintervention and postintervention. Data were analyzed using descriptive statistics and univariate conditional logistic regression models. OUTCOMES: Following workflow standardization, APPs noted increases of 27.1 percentage points in the proportion of women offered genetic testing and 26.4 percentage points in the genetic testing completion rate (26.4%). APPs agreed or strongly agreed that the workflow modification improved their confidence in performing HCRA (91.7%) and meeting the standard of care (91.7%) and supported guideline adherence (83.3%) and ease of practice integration (66.7%). DISCUSSION: APPs care for women with similar risk profiles as physicians and are equally capable of implementing novel tools and processes to provide evidence-based, personalized HCRA consistent with their scope of practice.

Indexed as

Genetic TestingNeoplasmsNurse PractitionersWomen's Health ServicesWorkflowAdultFemaleHumansMiddle AgedMidwiferyNurse MidwivesPatient Education as TopicProspective StudiesQuality ImprovementRisk AssessmentSurveys and Questionnairesadvanced practice providersgenetic testinghereditary cancer risk assessmentsmidwivesnurse practitionersonline patient screeningquality improvementvirtual patient educationworkflow optimization

Identifiers

PMID42047430
PMCPMC13655203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.